Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „these“
Suchtreffer
Begriffe & Kennungen
Duloxetine Viatris (previously Duloxetine Mylan) · 4.8 · Generally, for SSRIs and SNRIs, these events are mild to moderate and self-limiting, however, in some patients
Eintrag öffnenDuloxetine Zentiva · 4.8 · Generally, for SSRIs and SNRIs, these events are mild to moderate and self-limiting, however, in some patients
Eintrag öffnenDupixent · 4.8 · 73 group and 1.9 % of the placebo + TCS group. These rates remained stable at 5 years in the long-term OLE stu
Eintrag öffnenDynastat · 4.5 · 6 Therefore, the concomitant administration of these drugs should be done with caution. Patients should be ade
Eintrag öffnenDynastat · 4.5 · Therefore, the concomitant administration of these drugs should be done with caution. Patients should be adequ
Eintrag öffnenDzuveo · 4.5 · Caution should be exercised in patients on these concomitant medicinal products and they should be closely mon
Eintrag öffnenEDEM3-CDG
Eintrag öffnenEbvallo · 4.5 · For patients receiving chronic corticosteroid therapy, the dose of these drugs should be reduced as much as is
Eintrag öffnenEfavirenz Teva · 4.3 · Patients taking drugs that are known to prolong the QTc interval (proarrhythmic). These drugs include: - antia
Eintrag öffnenEfavirenz Teva · 4.5 · Efavirenz is an in vivo inducer of CYP3A4, CYP2B6 and UGT1A1. Compounds that are substrates of these enzymes m
Eintrag öffnenEfavirenz Teva · 4.5 · Efavirenz: no clinically significant interaction. The clinical significance of these effects is not known. Inj
Eintrag öffnenEfavirenz Teva · 4.8 · Information regarding post-marketing surveillance † These adverse reactions were identified through post-marke
Eintrag öffnenEfavirenz Teva · 4.8 · Patients with a history of psychiatric disorders appear to be at greater risk of these serious psychiatric adv
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.3 · Co administration with medicinal products that are known to prolong the QTc interval (proarrhythmic). These me
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · 9 efavirenz/emtricitabine/tenofovir disoproxil. Interaction studies with these agents have only been performed
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Efavirenz is an in vivo inducer of CYP3A4, CYP2B6 and UGT1A1. Compounds that are substrates of these enzymes m
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Efavirenz: no clinically significant interaction. The clinical significance of these effects is not known. Eth
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.3 · Co-administration with medicinal products that are known to prolong the QTc interval (proarrhythmic). These me
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · Efavirenz is an in vivo inducer of CYP3A4, CYP2B6 and UGT1A1. Compounds that are substrates of these enzymes m
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Zentiva · 4.3 · Co-administration with drugs that are known to prolong the QTc interval (proarrhythmic). These drugs include:
Eintrag öffnen